
51 - 200 employees
Founded 2014
🏥 Healthcare
🧬 Biotechnology
💊 Pharmaceuticals
Healthcare • Biotechnology • Pharmaceuticals
Ocular Therapeutix, Inc. is a company dedicated to advancing ophthalmic treatments through innovative technology. The company focuses on developing pharmaceutical therapies and drug delivery solutions for ocular diseases such as retinal diseases, glaucoma, and those requiring ophthalmic surgery. Ocular Therapeutix utilizes its proprietary ELUTYX™ technology to create preservative-free, sustained-release implants, aiming to improve patient outcomes by reducing the frequency of treatments. Their pipeline products include AXPAXLI™ and PAXTRAVA™, alongside marketed products like DEXTENZA® and ReSure® Sealant. The company is committed to enhancing vision health and provides career opportunities within a dynamic and inclusive workplace.
📡 We watch Ocular Therapeutix, Inc.'s careers page
Every 2 hours
how often we check
4
roles posted in the last 30 days
About 27 days
usual time to fill a role
12
roles closed in the last year
Selected: 🆕 Date Added.
🕒 October 6
VP leading market access, HEOR, pricing, and payer engagement for Ocular Therapeutix’s ophthalmic therapies. Shaping coverage, reimbursement, launch readiness, and patient access across the US payer landscape.
🕒 October 6
Corporate Accounts Director expanding Ocular Therapeutix’s ophthalmic products across Retina Consultants of America. Leading account strategy, access, contracting, negotiations, and senior stakeholder partnerships.
🕒 October 6
Executive leading national patient access, reimbursement, and support strategies for Ocular Therapeutix’s ophthalmic therapies. Building scalable teams and launch-ready infrastructure for Retina products.
🕒 October 6
Executive leading GPO and corporate account growth for Ocular Therapeutix, an ophthalmic biopharmaceutical company. Building Retina-focused teams, negotiating contracts, and managing strategic provider relationships.
🕒 September 18
Corporate Account Director developing strategic healthcare accounts and contracts for Ocular Therapeutix’s ophthalmic drug DEXTENZA. Driving access, partnerships, and revenue growth.
🇺🇸 United States – Remote
💵 $240k - $269k / year
⏰ Full Time
🔴 Lead
🧑💼 Account Executive
👻 Ghost score 18%